Cargando…

Leptin and risk factors for atherosclerosis: A review

Leptin is a hormone secreted primarily by adipose tissue. It regulates an organism’s metabolism, energy balance, and body weight through a negative feedback mechanism. When a person or animal has low body fat and little energy, the leptin level in the body decreases, and conversely, when there is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cheng, Chang, Liping, Wang, Jia, Xia, Libo, Cao, Liyuan, Wang, Wei, Xu, Jianwen, Gao, Huize
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659641/
https://www.ncbi.nlm.nih.gov/pubmed/37986371
http://dx.doi.org/10.1097/MD.0000000000036076
_version_ 1785148354586476544
author Wang, Cheng
Chang, Liping
Wang, Jia
Xia, Libo
Cao, Liyuan
Wang, Wei
Xu, Jianwen
Gao, Huize
author_facet Wang, Cheng
Chang, Liping
Wang, Jia
Xia, Libo
Cao, Liyuan
Wang, Wei
Xu, Jianwen
Gao, Huize
author_sort Wang, Cheng
collection PubMed
description Leptin is a hormone secreted primarily by adipose tissue. It regulates an organism’s metabolism, energy balance, and body weight through a negative feedback mechanism. When a person or animal has low body fat and little energy, the leptin level in the body decreases, and conversely, when there is an excess of nutrients, the leptin level increases, giving a feeling of satiety. However, when leptin levels are abnormal (too high or too low) for a number of reasons, it can negatively affect your health, inducing inflammatory responses, obesity, and other problems. Many studies have shown that abnormal leptin levels, such as hyperleptinemia, are closely associated with common risk factors for atherosclerosis (AS). This review systematically states the relationship between leptin and common risk factors for AS (inflammation, obesity, diabetes mellitus, hypertension, and sleep disorders) and provides some new thoughts on the future direction of research on both. Because the abnormal level of leptin will have adverse effects on multiple atherosclerotic risk factors, how to regulate the leptin level of patients with AS, and whether we can treat and prevent AS by intervening the leptin level, these may be our new research directions in the future.
format Online
Article
Text
id pubmed-10659641
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106596412023-11-17 Leptin and risk factors for atherosclerosis: A review Wang, Cheng Chang, Liping Wang, Jia Xia, Libo Cao, Liyuan Wang, Wei Xu, Jianwen Gao, Huize Medicine (Baltimore) 3400 Leptin is a hormone secreted primarily by adipose tissue. It regulates an organism’s metabolism, energy balance, and body weight through a negative feedback mechanism. When a person or animal has low body fat and little energy, the leptin level in the body decreases, and conversely, when there is an excess of nutrients, the leptin level increases, giving a feeling of satiety. However, when leptin levels are abnormal (too high or too low) for a number of reasons, it can negatively affect your health, inducing inflammatory responses, obesity, and other problems. Many studies have shown that abnormal leptin levels, such as hyperleptinemia, are closely associated with common risk factors for atherosclerosis (AS). This review systematically states the relationship between leptin and common risk factors for AS (inflammation, obesity, diabetes mellitus, hypertension, and sleep disorders) and provides some new thoughts on the future direction of research on both. Because the abnormal level of leptin will have adverse effects on multiple atherosclerotic risk factors, how to regulate the leptin level of patients with AS, and whether we can treat and prevent AS by intervening the leptin level, these may be our new research directions in the future. Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659641/ /pubmed/37986371 http://dx.doi.org/10.1097/MD.0000000000036076 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3400
Wang, Cheng
Chang, Liping
Wang, Jia
Xia, Libo
Cao, Liyuan
Wang, Wei
Xu, Jianwen
Gao, Huize
Leptin and risk factors for atherosclerosis: A review
title Leptin and risk factors for atherosclerosis: A review
title_full Leptin and risk factors for atherosclerosis: A review
title_fullStr Leptin and risk factors for atherosclerosis: A review
title_full_unstemmed Leptin and risk factors for atherosclerosis: A review
title_short Leptin and risk factors for atherosclerosis: A review
title_sort leptin and risk factors for atherosclerosis: a review
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659641/
https://www.ncbi.nlm.nih.gov/pubmed/37986371
http://dx.doi.org/10.1097/MD.0000000000036076
work_keys_str_mv AT wangcheng leptinandriskfactorsforatherosclerosisareview
AT changliping leptinandriskfactorsforatherosclerosisareview
AT wangjia leptinandriskfactorsforatherosclerosisareview
AT xialibo leptinandriskfactorsforatherosclerosisareview
AT caoliyuan leptinandriskfactorsforatherosclerosisareview
AT wangwei leptinandriskfactorsforatherosclerosisareview
AT xujianwen leptinandriskfactorsforatherosclerosisareview
AT gaohuize leptinandriskfactorsforatherosclerosisareview